These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31287314)

  • 1. Synthesis and Evaluation of Carbonic Anhydrase Inhibitors with Carbon Monoxide Releasing Properties for the Management of Rheumatoid Arthritis.
    Berrino E; Milazzo L; Micheli L; Vullo D; Angeli A; Bozdag M; Nocentini A; Menicatti M; Bartolucci G; di Cesare Mannelli L; Ghelardini C; Supuran CT; Carta F
    J Med Chem; 2019 Aug; 62(15):7233-7249. PubMed ID: 31287314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Insights on CAI-CORM Hybrids: Evaluation of the CO Releasing Properties and Pain-Relieving Activity of Differently Substituted Coumarins for the Treatment of Rheumatoid Arthritis.
    Berrino E; Micheli L; Carradori S; di Cesare Mannelli L; Guglielmi P; De Luca A; Carta F; Ghelardini C; Secci D; Supuran CT
    J Med Chem; 2023 Feb; 66(3):1892-1908. PubMed ID: 36701258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escinosome thermosensitive gel optimizes efficacy of CAI-CORM in a rat model of rheumatoid arthritis.
    Vanti G; Micheli L; Berrino E; Mannelli LDC; Bogani I; Carta F; Bergonzi MC; Supuran CT; Ghelardini C; Bilia AR
    J Control Release; 2023 Jun; 358():171-189. PubMed ID: 37121516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Carbonic Anhydrase IX/XII Inhibitors and Carbon Monoxide Releasing Molecules Modulate LPS-Mediated Inflammation in Mouse Macrophages.
    Berrino E; Carradori S; Angeli A; Carta F; Supuran CT; Guglielmi P; Coletti C; Paciotti R; Schweikl H; Maestrelli F; Cerbai E; Gallorini M
    Antioxidants (Basel); 2021 Jan; 10(1):. PubMed ID: 33466457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Management of Rheumatoid Arthritis.
    Akgul O; Di Cesare Mannelli L; Vullo D; Angeli A; Ghelardini C; Bartolucci G; Alfawaz Altamimi AS; Scozzafava A; Supuran CT; Carta F
    J Med Chem; 2018 Jun; 61(11):4961-4977. PubMed ID: 29746127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis.
    Bua S; Di Cesare Mannelli L; Vullo D; Ghelardini C; Bartolucci G; Scozzafava A; Supuran CT; Carta F
    J Med Chem; 2017 Feb; 60(3):1159-1170. PubMed ID: 28075587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioisosteric Development of Multitarget Nonsteroidal Anti-Inflammatory Drug-Carbonic Anhydrases Inhibitor Hybrids for the Management of Rheumatoid Arthritis.
    Bua S; Lucarini L; Micheli L; Menicatti M; Bartolucci G; Selleri S; Di Cesare Mannelli L; Ghelardini C; Masini E; Carta F; Gratteri P; Nocentini A; Supuran CT
    J Med Chem; 2020 Mar; 63(5):2325-2342. PubMed ID: 31689108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
    Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications.
    Winburn IC; Gunatunga K; McKernan RD; Walker RJ; Sammut IA; Harrison JC
    Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):31-41. PubMed ID: 22269084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII.
    Angapelly S; Sri Ramya PV; Angeli A; Supuran CT; Arifuddin M
    ChemMedChem; 2017 Oct; 12(19):1578-1584. PubMed ID: 28940980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain Relieving Effect of-NSAIDs-CAIs Hybrid Molecules: Systemic and Intra-Articular Treatments against Rheumatoid Arthritis.
    Micheli L; Bozdag M; Akgul O; Carta F; Guccione C; Bergonzi MC; Bilia AR; Cinci L; Lucarini E; Parisio C; Supuran CT; Ghelardini C; Di Cesare Mannelli L
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003542
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel Diamide-Based Benzenesulfonamides as Selective Carbonic Anhydrase IX Inhibitors Endowed with Antitumor Activity: Synthesis, Biological Evaluation and In Silico Insights.
    Abdelrahman MA; Eldehna WM; Nocentini A; Bua S; Al-Rashood ST; Hassan GS; Bonardi A; Almehizia AA; Alkahtani HM; Alharbi A; Gratteri P; Supuran CT
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII.
    Esirden İ; Ulus R; Aday B; Tanç M; Supuran CT; Kaya M
    Bioorg Med Chem; 2015 Oct; 23(20):6573-80. PubMed ID: 26422787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs.
    Carta F; Vullo D; Osman SM; AlOthman Z; Supuran CT
    Bioorg Med Chem; 2017 May; 25(9):2569-2576. PubMed ID: 28347633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors.
    Nocentini A; Moi D; Balboni G; Onnis V; Supuran CT
    Bioorg Chem; 2018 Apr; 77():293-299. PubMed ID: 29421705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
    Sarikaya B; Ceruso M; Carta F; Supuran CT
    Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First evaluation of organotellurium derivatives as carbonic anhydrase I, II, IV, VII and IX inhibitors.
    Angeli A; Tanini D; Capperucci A; Supuran CT
    Bioorg Chem; 2018 Feb; 76():268-272. PubMed ID: 29223030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule.
    Motterlini R; Sawle P; Hammad J; Bains S; Alberto R; Foresti R; Green CJ
    FASEB J; 2005 Feb; 19(2):284-6. PubMed ID: 15556971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies.
    Abo-Ashour MF; Eldehna WM; Nocentini A; Ibrahim HS; Bua S; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2018 Sep; 157():28-36. PubMed ID: 30071407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.